According to a new report from Intel Market Research, the Europe Rail Signalling System market was valued at USD 2.8 billion in 2024 and is projected to reach USD 4.2 billion by 2030, growing at a CAGR of 7.0% during the forecast period (2025–2030). This steady growth is fueled by extensive rail modernization initiatives, implementation of the European Rail Traffic Management System (ERTMS), and increasing demand for automated train control solutions across the continent.
Read MoreAccording to a new report from Intel Market Research, the Europe boat steering systems market was valued at USD 345.6 million in 2024 and is projected to reach USD 498.7 million by 2030, growing at a CAGR of 6.3% during the forecast period (2025-2030). This growth is driven by increasing recreational boating activities, technological advancements in marine control systems, and rising naval defense expenditures across European coastal nations.
Read MoreAccording to a new report from Intel Market Research, the global Consumer Use IPL (Intense Pulsed Light) Hair Removal market was valued at USD 1.19 billion in 2024 and is projected to reach USD 1.75 billion by 2034, growing at a CAGR of 5.4% during the forecast period (2025-2034). This growth is driven by increasing consumer preference for at-home beauty solutions, technological advancements in IPL devices, and rising disposable incomes in emerging markets.
Read MoreAccording to a new report from Intel Market Research, the global At-home Use IPL (Intense Pulsed Light) Hair Removal System market was valued at USD 1.16 billion in 2024 and is projected to reach USD 1.67 billion by 2034, growing at a CAGR of 5.4% during the forecast period (2025–2034). This growth is driven by increasing consumer demand for convenient, salon-alternative solutions and technological advancements in IPL devices.
Read MoreAccording to a new report from Intel Market Research, the global sertraline market was valued at US$ 7.4 billion in 2024 and is projected to reach US$ 9.8 billion by 2032, growing at a CAGR of 3.7% during the forecast period (2024–2032). This sustained growth is primarily driven by the escalating global prevalence of mental health disorders, increasing awareness about antidepressant treatments, and expanding accessibility through generic drug availability.
Read More